Search results for "Dementia"

showing 10 items of 542 documents

2019

Objective. Several studies have reported that people with Parkinson’s disease (PD) perform poorly on tests of ‘Theory of Mind’ (ToM), suggesting impairment in the ability to understand and infer other people’s thoughts and feelings. However, few studies have sought to separate the processes involved in social reasoning from those involved in managing the inhibitory demands on these tests. In this study, we investigated the contribution of inhibition to ToM performance in PD. Methods. 18 PD patients and 22 age-matched healthy controls performed a ToM test that separates the ability to infer someone else’s perspective from the ability to inhibit one’s own. Participants also completed a batter…

Dissociation (neuropsychology)Parkinson's diseasebusiness.industrymedia_common.quotation_subject05 social sciencesNeuroscience (miscellaneous)CognitionDiseasemedicine.disease050105 experimental psychology03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineFeelingSocial cognitionTheory of mindmedicineDementia0501 psychology and cognitive sciencesNeurology (clinical)business030217 neurology & neurosurgerymedia_commonClinical psychologyParkinson's Disease
researchProduct

Syndrome démentiel du sujet âgé lié à un traitement par acide valproïque : à propos d’un cas

2008

In addition to the usual adverse effects, the chronic use of the valproic acid can entail dementia syndrome. We describe the case of a 68-year-old woman who had presented a dementia syndrome due to the use of valproic acid for one year. This drug was prescribed in order to prevent a potential convulsive crisis after an ischemic stroke in a patient who did not have a history of epilepsy. This case shows that each clinician must be careful about all medications consumed by the patient in the face of cognitive disorders.

DrugValproic Acidmedicine.medical_specialtyPediatricsmedicine.drug_classbusiness.industrymedia_common.quotation_subjectmedicine.medical_treatmentGastroenterologyMood stabilizermedicine.diseaseSurgeryEpilepsyAnticonvulsantIschemic strokeInternal MedicinemedicineDementiabusinessAdverse effectmedicine.drugmedia_commonLa Revue de Médecine Interne
researchProduct

The Effectiveness of Vitamin E Treatment in Alzheimer’s Disease

2019

Vitamin E was proposed as treatment for Alzheimer’s disease many years ago. However, the effectiveness of the drug is not clear. Vitamin E is an antioxidant and neuroprotector and it has anti-inflammatory and hypocholesterolemic properties, driving to its importance for brain health. Moreover, the levels of vitamin E in Alzheimer’s disease patients are lower than in non-demented controls. Thus, vitamin E could be a good candidate to have beneficial effects against Alzheimer’s. However, evidence is consistent with a limited effectiveness of vitamin E in slowing progression of dementia; the information is mixed and inconclusive. The question is why does vitamin E fail to tre…

Drugbrain healthAntioxidantmedicine.medical_treatmentmedia_common.quotation_subjectReviewDiseaseBioinformaticsCatalysislcsh:ChemistryInorganic ChemistryAlzheimer DiseasemedicineHumansVitamin EDementiaPhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologyBeneficial effectsSpectroscopymedia_commonClinical Trials as Topicnon-respondentsbusiness.industryVitamin EOrganic ChemistryCognitionGeneral Medicinemedicine.diseaseComputer Science ApplicationsOxidative StressTreatment Outcomeantioxidantslcsh:Biology (General)lcsh:QD1-999respondents to vitamin ECognition DisordersbusinessAlzheimer’s diseaseInternational Journal of Molecular Sciences
researchProduct

Lenalidomide induced reversible parkinsonism, dystonia, and dementia in subclinical Creutzfeldt-Jakob disease

2018

DystoniaPediatricsmedicine.medical_specialtybusiness.industryParkinsonismPrion diseaseDiseaseParkinsonismmedicine.disease030226 pharmacology & pharmacyCreutzfeldt-Jakob disease03 medical and health sciences0302 clinical medicineNeurologymedicineDementiaNeurology (clinical)businessLenalidomide030217 neurology & neurosurgerySubclinical infectionLenalidomidemedicine.drugJournal of the Neurological Sciences
researchProduct

Carga global, regional y nacional de neurológicas. Desórdenes, 1990-2016: un análisis sistemático para el Global Estudio de la carga de enfermedad 20…

2019

Publisher´s version (útgefin grein).

DánarmeinMaleEpidemiologyDiseasesMalalties cerebralsGlobal Burden of DiseaseDisability Evaluation0302 clinical medicineCase fatality ratePsychologyKonurCause of deathAged 80 and overeducation.field_of_studyIncidenceMenTaugavísindiddc:3. Good healthSálfræðiWorld healthMuerteNeurologyGBD 2016 Neurology CollaboratorsBrain diseasesQuality-Adjusted Life YearsAlzheimer diseaseCarga global de enfermedadesNervous systemmedicine.medical_specialtyGlobal burden of diseasesLífsgæðiArticle03 medical and health sciencesHealth SciencesHumansWomeneducationTrastornos neurológicosVLAGAgedScience & Technology3112 NeurosciencesGlobal Burden of Diseases030104 developmental biologyYears of potential life lostΕπιστήμες ΥγείαςDementiaHuman medicineNeurosciences & NeurologyNeurology (clinical)Clinical Medicine1109 NeurosciencesNeurological disorders030217 neurology & neurosurgerydementiaRC0301 basic medicinePediatricsDánartíðniNutrition and Disease3124 Neurology and psychiatryDisease StudyTaugasjúkdómarRisk FactorsVoeding en ZiekteCause of DeathGlobal healthPrevalenceNeurological disorders; Global Burden of DiseasesCauses of deathPublic healthMortality rateMental DisordersAge FactorsPublic Health Global Health Social Medicine and EpidemiologyMiddle Agedneurologic diseaseDeathLýðheilsaFemaleLife Sciences & BiomedicineQuality of lifeAdultPopulationClinical NeurologySex FactorsmedicineLife ScienceDisability-adjusted life year:Medicine [Science]MortalityPsychiatryDisease burdenNeurology & Neurosurgeryburden of neurological disordersFaraldsfræðibusiness.industryKlinisk medicinCauses de la mort1103 Clinical SciencesFolkhälsovetenskap global hälsa socialmedicin och epidemiologiSocioeconomic FactorsKarlarglobal disease burdenNervous System DiseasesCause of death/trendsbusiness
researchProduct

Studio di validazione dell'ACE-R in lingua italiana nella popolazione degli young-old e degli old-old

2012

Introduction. The main aims of the study were the translation into Italian, and validation subsequently of the Addenbrooke's Cognitive Examination Revised (ACE-R), and the evaluation of its usefulness in discriminating cognitively normal subjects from patients with mild dementia. Methods. The ACE-R was translated and adapted into Italian. The Italian ACE-R was administrated to a group of 179 elderly subjects (72 cognitively intact and 107 subjects with mild dementia, mean age 75.4 years ± 6.4). The group was stratified in two sub-samples according to age, i.e. young-old (< 75 years) and old-old (≥ 75 years), in order to evaluate test's sensitivity and specificity in detecting dementia among…

ElderlyCognitive assessmentAddenbrooke’s Cognitive Examination; Elderly; Dementia; Cognitive assessment; Young-old; Old-oldDementiaYoung-oldOld-oldSettore MED/26 - NeurologiaAddenbrooke's Cognitive ExaminationCognitive assessmentDementiaElderlyOld-oldYoung-oldAddenbrooke’s Cognitive Examination
researchProduct

The Impact of Using Measurements of Electrodermal Activity in the Assessment of Problematic Behaviour in Dementia

2018

Background: A major and complex challenge when trying to support individuals with dementia is meeting the needs of those who experience changes in behaviour and mood. Aim: To explore how a sensor measuring electrodermal activity (EDA) impacts assistant nurses’ structured assessments of problematic behaviours amongst people with dementia and their choices of care interventions. Methods: Fourteen individuals with dementia wore a sensor that measured EDA. The information from the sensor was presented to assistant nurses during structured assessments of problematic behaviours. The evaluation process included scorings with the instrument NPI-NH (Neuropsychiatric Inventory-Nursing Home version), …

Electrodermal activitylcsh:RC952-954.6Dementia careNursing homesDementiaOriginal Research ArticleBehavioural psychological symptoms in dementialcsh:Geriatricslcsh:Neurology. Diseases of the nervous systemlcsh:RC346-429Dementia and Geriatric Cognitive Disorders Extra
researchProduct

&lt;p&gt;Systematic Use of Song and Music in Dementia Care: Health Care Providers’ Experiences&lt;/p&gt;

2020

Background and aim Using song and music in a systematic way in residential dementia care may have several positive impacts on the patients, as well as the care providers. The aim of this study was to explore how health care providers experienced taking responsibility for conducting a song and music program in dementia care in nursing homes. Methods An explorative, qualitative study design was used. Focus groups were formed by 17 health care providers from 3 different nursing homes. These providers had experience implementing and using the "Gjenklang" ("reverberation") song and music program especially developed for people with dementia. Focus group interviews were transcribed verbatim, and …

EnthusiasmMusic therapybusiness.industry030503 health policy & servicesmedia_common.quotation_subjectGeneral Medicinemedicine.diseaseFocus grouphumanitiesPeer review03 medical and health sciences0302 clinical medicineNursingHealth caremedicineDementia030212 general & internal medicineConsciousness0305 other medical sciencePsychologybusinessGeneral Nursingmedia_commonQualitative researchJournal of Multidisciplinary Healthcare
researchProduct

P4‐244: Progranulin (GRN), a protein mutated in frontotemporal dementia with ubiquitin‐positive inclusions (FTLD‐U), is abundantly expressed in human…

2009

EpidemiologyHealth PolicyA proteinBiologymedicine.diseaseUbiquitin-positive inclusionsPsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceCancer researchmedicineNeurology (clinical)Geriatrics and GerontologyFrontotemporal dementiaAlzheimer's &amp; Dementia
researchProduct

P4‐117: Low mood in late life and risk of amnestic versus other cognitive impairment with and without dementia: A longitudinal community‐based study

2008

EpidemiologyHealth Policymedicine.diseaseCommunity based studyPsychiatry and Mental healthCellular and Molecular NeuroscienceMoodDevelopmental NeurosciencemedicineDementiaNeurology (clinical)Geriatrics and GerontologyCognitive impairmentPsychologyClinical psychologyCognitive psychologyAlzheimer's &amp; Dementia
researchProduct